Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoichi Fukui

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Arthritis Research & Therapy|May 27, 2017
Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power Doppler synovitis activity and clinical disease activity are well controlledShin-Ya Kawashiri, Keita Fujikawa, Ayako Nishino, et al.
American Journal of Hematology|January 26, 2025
Exploring the Clinical Diversity of Castleman Disease and TAFRO Syndrome: A Japanese Multicenter Study on Lymph Node Distribution PatternsMizuna Otsuka, Tomohiro Koga, Remi Sumiyoshi, et al.
Internal Medicine (Tokyo, Japan)|January 12, 2018
Peripheral Ulcerative Keratitis Associated with Granulomatosis with Polyangiitis Emerging Despite Cyclophosphamide, Successfully Treated with RituximabYuya Fujita, Shoichi Fukui, Yushiro Endo, et al.
Scientific Reports|January 26, 2019
Serum levels of fibroblast growth factor-2 distinguish Takayasu arteritis from giant cell arteritis independent of age at diagnosisShoichi Fukui, Ayako Kuwahara-Takaki, Nobuyuki Ono, et al.
Scientific Reports|June 13, 2020
Comparison of lung microbiota between antineutrophil cytoplasmic antibody-associated vasculitis and sarcoidosisShoichi Fukui, Shimpei Morimoto, Kunihiro Ichinose, et al.
Journal of Bone and Mineral Metabolism|September 7, 2018
Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugsNaoki Iwamoto, Momoko Okamoto, Sosuke Tsuji, et al.
Arthritis Research & Therapy|May 9, 2020
Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsisTomohiro Koga, Remi Sumiyoshi, Kaori Furukawa, et al.
Clinical Immunology (Orlando, Fla.)|November 23, 2017
Novel anti-suprabasin antibodies may contribute to the pathogenesis of neuropsychiatric systemic lupus erythematosusKunihiro Ichinose, Kaname Ohyama, Kaori Furukawa, et al.
Clinical Immunology (Orlando, Fla.)|October 17, 2017
CD4<sup>+</sup> CD52<sup>lo</sup> T-cell expression contributes to the development of systemic lupus erythematosusMasataka Umeda, Tomohiro Koga, Kunihiro Ichinose, et al.
Immunological Medicine|January 12, 2019
Efficacy of infliximab as a switched biologic in rheumatoid arthritis patients in daily clinical practiceMasataka Umeda, Tomohiro Koga, Kunihiro Ichinose, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Arthritis Research & Therapy|May 27, 2017
Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power Doppler synovitis activity and clinical disease activity are well controlledShin-Ya Kawashiri, Keita Fujikawa, Ayako Nishino, et al.
American Journal of Hematology|January 26, 2025
Exploring the Clinical Diversity of Castleman Disease and TAFRO Syndrome: A Japanese Multicenter Study on Lymph Node Distribution PatternsMizuna Otsuka, Tomohiro Koga, Remi Sumiyoshi, et al.
Internal Medicine (Tokyo, Japan)|January 12, 2018
Peripheral Ulcerative Keratitis Associated with Granulomatosis with Polyangiitis Emerging Despite Cyclophosphamide, Successfully Treated with RituximabYuya Fujita, Shoichi Fukui, Yushiro Endo, et al.
Scientific Reports|January 26, 2019
Serum levels of fibroblast growth factor-2 distinguish Takayasu arteritis from giant cell arteritis independent of age at diagnosisShoichi Fukui, Ayako Kuwahara-Takaki, Nobuyuki Ono, et al.
Scientific Reports|June 13, 2020
Comparison of lung microbiota between antineutrophil cytoplasmic antibody-associated vasculitis and sarcoidosisShoichi Fukui, Shimpei Morimoto, Kunihiro Ichinose, et al.
Journal of Bone and Mineral Metabolism|September 7, 2018
Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugsNaoki Iwamoto, Momoko Okamoto, Sosuke Tsuji, et al.
Arthritis Research & Therapy|May 9, 2020
Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsisTomohiro Koga, Remi Sumiyoshi, Kaori Furukawa, et al.
Clinical Immunology (Orlando, Fla.)|November 23, 2017
Novel anti-suprabasin antibodies may contribute to the pathogenesis of neuropsychiatric systemic lupus erythematosusKunihiro Ichinose, Kaname Ohyama, Kaori Furukawa, et al.
Clinical Immunology (Orlando, Fla.)|October 17, 2017
CD4<sup>+</sup> CD52<sup>lo</sup> T-cell expression contributes to the development of systemic lupus erythematosusMasataka Umeda, Tomohiro Koga, Kunihiro Ichinose, et al.
Immunological Medicine|January 12, 2019
Efficacy of infliximab as a switched biologic in rheumatoid arthritis patients in daily clinical practiceMasataka Umeda, Tomohiro Koga, Kunihiro Ichinose, et al.
Pageof 13